|
Volumn 175, Issue 2, 2001, Pages 91-92
|
The antivenin is safe, but its future is uncertain
|
Author keywords
[No Author keywords available]
|
Indexed keywords
VENOM ANTISERUM;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
HUMAN;
NOTE;
SNAKEBITE;
URTICARIA;
ANTIVENINS;
HUMANS;
IMMUNOGLOBULIN FRAGMENTS;
SNAKE BITES;
|
EID: 0034862177
PISSN: 00930415
EISSN: None
Source Type: Journal
DOI: 10.1136/ewjm.175.2.91 Document Type: Note |
Times cited : (3)
|
References (2)
|